Keyphrases
Thyroid Hormones
100%
Integrin
73%
Myeloproliferative Neoplasms
58%
Venous Thromboembolism
57%
Anticoagulation
53%
Israel
47%
Thrombosis
44%
Ovarian Cancer
40%
Confidence Interval
40%
Anemia
38%
Israeli
34%
Antiphospholipid Syndrome
33%
Direct Oral Anticoagulants
31%
Low Molecular Weight Heparin
30%
Platelets
29%
Polycythemia Vera
29%
Hazard Ratio
29%
Myelofibrosis
27%
OVCAR-3
26%
Tranexamic Acid
26%
Total Knee Replacement
26%
Chronic Myeloid Leukemia
26%
Bleeding
26%
Major Bleeding
26%
Anticoagulants
26%
Essential Thrombocythemia
24%
Thrombophilia
24%
Vena Cava Filters
23%
High-grade Serous Ovarian Cancer (HGSOC)
23%
Venous Thrombosis
23%
Recurrent Venous Thromboembolism
23%
Atrial Fibrillation
22%
Deep Vein Thrombosis
22%
Transfusion
22%
Blood Storage
22%
Myeloma Cells
22%
Clinical Significance
21%
Warfarin
21%
Red Cells
21%
Enoxaparin
20%
Pulmonary Embolism
20%
Splanchnic Vein Thrombosis
20%
Hematological Malignancies
20%
Physician Survey
19%
Hemophagocytic Lymphohistiocytosis
19%
Tyrosine Kinase Inhibitor
19%
Bone Marrow
19%
Tumor Growth
18%
Risk Factors
17%
Clinical Outcomes
17%
Medicine and Dentistry
Thyroid Hormone
65%
Venous Thromboembolism
64%
Anticoagulation
60%
Myeloproliferative Neoplasm
56%
Integrin
55%
Disease
53%
Thrombosis
49%
Ovarian Cancer
47%
Phlebothrombosis
40%
Antithrombotic
36%
Malignant Neoplasm
35%
Bleeding
33%
Anemia
32%
Platelet
27%
Major Bleeding
26%
Antiphospholipid Syndrome
26%
Venae cavae
26%
Hazard Ratio
25%
Inferior Vena Cava Filter
25%
Prevalence
25%
Internal Medicine
23%
Myelofibrosis
23%
Retrospective Study
23%
Low Molecular Weight Heparin
22%
Erythrocyte
22%
Polycythemia vera
21%
Recurrent Disease
21%
Pulmonary Embolism
21%
Thromboembolism
21%
Deep Vein Thrombosis
20%
Hematologic Malignancy
20%
Tranexamic Acid
19%
Total Knee Arthroplasty
19%
Hemophagocytic Syndrome
19%
Symptom
19%
Cancer
18%
Infection
17%
Direct Oral Anticoagulant
17%
B-Cell Chronic Lymphocytic Leukemia
17%
Thrombophilia
17%
Thrombocytosis
16%
Cell Line
16%
Antiphospholipid Antibody
16%
Randomized Controlled Trial
15%
Blood Storage
15%
Mitogen-Activated Protein Kinase
15%
Odds Ratio
15%
Neoplasm
14%
Thyroid Hormone Derivative
14%
Hematoma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Hormone
80%
Venous Thromboembolism
61%
Bleeding
57%
Malignant Neoplasm
49%
Integrin
47%
Disease
43%
Ovary Cancer
39%
Anticoagulant Agent
34%
Direct Oral Anticoagulant
28%
Myeloma
28%
Thromboembolism
27%
Myelofibrosis
26%
Low Molecular Weight Heparin
26%
Tranexamic Acid
26%
Myeloproliferative Neoplasm
23%
Thrombosis
23%
Neoplasm
23%
Atrial Fibrillation
21%
Warfarin
21%
Multiple Myeloma
20%
Chronic Lymphatic Leukemia
19%
Chronic Myeloid Leukemia
19%
Anemia
19%
Hematologic Malignancy
18%
Thrombin
17%
Infection
16%
Polycythemia vera
16%
Clinical Study
16%
Symptom
15%
Ruxolitinib
15%
Vein Thrombosis
15%
Randomized Controlled Trial
15%
Deep Vein Thrombosis
14%
Cohort Study
14%
Thyroid Hormone Derivative
14%
Tumor Growth
14%
Blood Clotting Factor 10a
13%
Enoxaparin
13%
Cardiolipin Antibody
13%
Hemophagocytic Syndrome
13%
Thrombotic Thrombocytopenic Purpura
13%
Nonhodgkin Lymphoma
13%
Phosphatidylserine
13%
Desmopressin
13%
Dexamethasone
13%
Momelotinib
13%
Protein Tyrosine Kinase Inhibitor
13%
Danazol
13%
Myelodysplastic Syndrome
11%
Lung Embolism
11%